FDA resets decision date on Incyte's GVHD treatment application
February 07, 2019 at 11:18 AM EST
A ruling on the Wilmington biotech company's supplemental application for Jakafi will occur in May.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.